Uncategorized

Eli Lilly’s Oral Obesity Pill Approved, Kicking Off Renewed Novo Rivalry

Published

6 days ago

on

The FDA approved Eli Lilly’s orforglipron—to be known as Foundayo—on Wednesday, officially igniting what analysts believe will be a fierce rivalry with Novo Nordisk’s oral Wegovy.

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version